Grafa News and Videos — Page 823

Ryanair Holdings plc (NASDAQ:RYAAY) reported its finalized, record-breaking financial results for the fiscal year ended March 31, 2026 (FY26), highlighting explosive bottom-line performance, strategic fuel defenses, and significant corporate restructuring.

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) announced positive chemistry, manufacturing, and controls (CMC) data supporting the late-stage development of its lead antimicrobial candidate, Nu-3.

C3is (NASDAQ:CISS) announced its financial and operational results for the first quarter ended March 31, 2026, delivering substantial bottom-line expansion and enhanced operating leverage.

INNEOVA Holdings (NASDAQ:INEO) announced its audited financial results for the fiscal year ended December 31, 2025, charting a period of transition and operational realignment.

Design Therapeutics (NASDAQ:DSGN) announced positive biomarker and clinical findings from its ongoing Phase 1/2 RESTORE-FA clinical trial evaluating DT-216P2 in individuals with Friedreich ataxia (FA).

Brady Corporation (NYSE:BRC) reported its financial results for the fiscal 2026 third quarter ended April 30, 2026, delivering substantial top-line acceleration and record-setting profitability metrics.

AstraZeneca (NASDAQ:AZN) announced that the U.S. Food and Drug Administration (FDA) has approved BAXFENDY™ (baxdrostat) for the treatment of hypertension in adults.

WeTouch Technology (NASDAQ:WETH) reported its unaudited financial results for the first quarter ended March 31, 2026, delivering significant bottom-line acceleration and stable revenue growth.

NextEra Energy (NYSE:NEE) announced Monday a definitive agreement to acquire Dominion Energy (NYSE:D) in an all-stock transaction valued at approximately $67 billion.

Ondas Holdings (NASDAQ:ONDS) has signed a definitive agreement to acquire 100% of Omnisys, an Israeli-based developer of advanced, AI-powered Battle Resource Optimization (BRO) software.